Copyright
©The Author(s) 2021.
Artif Intell Gastroenterol. Apr 28, 2021; 2(2): 42-55
Published online Apr 28, 2021. doi: 10.35712/aig.v2.i2.42
Published online Apr 28, 2021. doi: 10.35712/aig.v2.i2.42
Table 1 Recent developments in artificial intelligence assisted diagnosis
AI category | Data adopted | Advantages | Control | Ref. |
ANN | Preoperative serum AFP, tumor number, size and volume | The ANN showed higher AUCs in identifying tumor grade (0.94) and MVI (0.92) | LR model (0.85 and 0.85) | [20] |
CNN | Enhanced MRI | The CNN showed comparable accuracy (90%) | Traditional multiphase MRI (89%) | [24,25] |
Open-source framework “caffe” based CNN model | DWI | CNN trained with three sets of b-values found better grading accuracy (80%) | CNN trained with different b-values (65%, 68%, 70%) | [26] |
CNN | Nonenhanced MRI | The deeply supervised and pretrained CNN model performed better in characterizing HCC (accuracy 77.00 ± 1.00%) | CNN-based method pretrained by ImageNet (65.00 ± 1.58%) | [27] |
DL-based segmentation model | Contrast-enhanced CT | The model with a combination of 2D multiphase strategy showed higher ability of segmenting active part from the tumors | Traditional CT estimation | [28-30] |
RF based ML model | HE-stained histopathological images | The classifying model showed an AUC of 0.988 in the test set and 0.886 in the external validation set | - | [31] |
1D CNN | Hyperspectral and HE-stained images | The models had a higher average AUC of 0.950 | RF (0.939) and SVM (0.930) models | [33] |
Shiny and Caret packages-based prediction model | Clinical and laboratorial information | The optimal model had an AUC of 0.943 | Single factor-based predictors (0.766, 0.644 and 0.683) | [34] |
- Citation: Yi PS, Hu CJ, Li CH, Yu F. Clinical value of artificial intelligence in hepatocellular carcinoma: Current status and prospect. Artif Intell Gastroenterol 2021; 2(2): 42-55
- URL: https://www.wjgnet.com/2644-3236/full/v2/i2/42.htm
- DOI: https://dx.doi.org/10.35712/aig.v2.i2.42